Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00943800 · FLOW

Participant flow

Combined Haploidentical-Cord Blood Transplantation for Adults and Children · Source last updated 2021-01-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Although the protocol initially had different disease intensities, ultimately, moved to one regimen for all patients. Subjects received 30mg/m\^2 of Fludarabine from Day-7 until Day-3, 140mg/m\^2 of Melphalan on Day-2, and 1.5mg/kg of Rabbit antithymocyte globulin at Day-7,-5,-3 and -1."
    id
    FG000
    title
    Treatment Group
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        87
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        87
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Although the protocol initially had different disease intensities, ultimately, moved to one regimen for all patients. Subjects received 30mg/m\^2 of Fludarabine from Day-7 until Day-3, 140mg/m\^2 of Melphalan on Day-2, and 1.5mg/kg of Rabbit antithymocyte globulin at Day-7,-5,-3 and -1."
    id
    FG000
    title
    Treatment Group
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        87
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        87
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice